Drug Repositioning for Dermatophyte Infections: Assessing Efficacy and Dermal Safety

This study explores the antidermatophytic potential and acute dermal toxicity of approved drugs, addressing the challenge of fungal resistance to existing therapies. Current antifungal treatments involve azoles, polyenes, allylamines, and echinocandins and other miscellaneous drugs. However, the rising resistance to these options prompted us to investigate alternative therapies using both in silico and in vitro methods, focusing on sterol 14α-demethylase- a key enzyme targeted by antifungal azoles. We selected antiepileptic drugs with similar pharmacophores as potential ligands. These compounds were sourced from PubChem, while the target proteins were obtained from the Protein Data Bank. Molecular docking and Molecular Dynamics (MD) simulations were performed using the Prescience In Silico Solution Suite (version V 2.1.0) to compare the binding efficiency of the selected ligands with two proteins: Human lanosterol 14-alpha-demethylase (PDB ID: 3LD6) and fungal lanosterol 14-alpha-demethylase (PDB ID: 5V5Z). Among the tested compounds, Nirvanol, Mephytoin, and Phenytoin exhibited effective binding to both proteins. Notably, Phenytoin demonstrated an average RMSD of 0.198 for the human protein and 0.146 for the fungal protein, with interaction energies of -146.05 kJ/mol and -191.64 kJ/mol, respectively. In vitro assays revealed that Phenytoin’s minimum inhibitory concentrations were 2.5 mg/ml for Microsporum canis, 10 mg/ml for Trichophyton rubrum, and 1.25 mg/ml for Epidermophyton floccosum - significantly higher than standard antifungals like Itraconazole and Ketoconazole (0.01-0.02 mg/ml). Additionally, skin sensitization and acute dermal toxicity tests were conducted to assess safety. The findings suggest that Phenytoin, despite its liver-related side effects, has potential as an antifungal agent when used alongside bioactive compounds to mitigate toxicity. Major Findings: This study evaluated the antifungal potential of antiepileptic drugs, identifying Phenytoin

View article page

Download PDF